Mark Connors

14PUBLICATIONS
147CO-AUTHORS
GlycoconjugatesNanotoxicology, health and safetyInnate immunityBiomedical instrumentationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 14, 2026
Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields.

|May 25, 2026
Transgene Expression Kinetics and Replication Potential of Recombinant Adenovirus Serotype 4 in a Mouse Model and its Use as a Herpes Simplex Virus Vaccine.

|Apr 15, 2026
A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders.

Janaki Kuruppu, Julia B Purdy, Cheryl Pauls

|Mar 09, 2026
Safety, immunovirological, and CNS effects of PD-1 inhibition in people with HIV without malignancy.

Lauren B Reoma, Tory P Johnson, Ken Cheung

|Nov 12, 2025
Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccine.

Wataru Akahata, Mai Komori, Amber L Morey

|Jun 03, 2025
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response.

Kenta Matsuda, Mitra Harrison, Eleanor Wettstein

Pageof 3

Frequent Collaborators

4 joint publications

Nicole Doria-Rose

4 joint publications

Peter D Kwong

3 joint publications

Tongqing Zhou

3 joint publications

Daniel Rogan